The Prevention Of Postmenopausal Osteoporosis With Lasofoxifene And Cytokine Evaluation

Status:
Completed

Trial end date:
2007-09-01

Target enrollment:

Participant gender:

The objective of the study is to demonstrate the effects that lasofoxifene has on serum markers of bone metabolism.

Phase 2

Ligand Pharmaceuticals